Company intelligence / Profile preview

NRGene

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

NRGene has successfully commercialized its AI-driven genomic analysis platforms to accelerate natural breeding in plants and animals. Its technology has been used in over 300 projects globally with major agri-food companies to create disease-resistant, climate-resilient crops with improved nutritional profiles. The company’s tools have enabled rapid genome assembly—such as assembling the complex wheat genome in just ten days—and are widely adopted by leading industry players.

Industry: Agriculture & AgTech

Partnerships

Monsanto/Bayer Crop ScienceSyngentaAdamaTop Seeds International/Mitsui & Co. Ltd.Bühler GroupBridgestoneNestléSuntoryMondelez

Beyond the preview

Go deeper on NRGene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NRGene.

Explore the full profile